透明质酸原料市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

市场按应用(骨科、眼科、药物输送、皮肤科)最终用户和地理划分。

市场快照

hyaluronic acid raw material
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 6.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

研究的全球透明质酸原料市场预计在预测期内的复合年增长率为 6.5%。透明质酸在化妆品和医疗领域的使用越来越多,对抗衰老解决方案和微创美容治疗的需求不断增长,这些都是有望引发市场增长的主要趋势。不断增长的老年人口基数导致该人群采用抗衰老解决方案。此外,Zimmer Biomet 和 Genzyme Corporation 等公司增加对新产品开发的投资已推出单次注射产品,促进了新的单次注射透明质酸 Visco 补充剂的渗透,估计将为市场提供显着推动力。此外,关节炎患病率的增加和患者对关节炎疾病意识的提高预计将增加透明质酸原料的采用。2019 年,美国约有 5400 万成年人患有关节炎。独自的。

然而,与使用透明质酸相关的高成本和副作用可能会抑制市场的增长。

报告范围

根据范围,透明质酸天然存在于人体内,在眼睛和关节的液体中含量很高。这些用于各种类型的关节疾病,例如骨关节炎和关节疼痛。透明质酸原料市场按应用、最终用户和地理划分。

By Application
Orthopedics
Ophthalmology
Drug Delivery
Dermatology
Others
By End User
Hospitals
Cosmetic Clinics
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

骨科领域有望主导市场

按应用划分的骨科部门预计将在预测期内主导全球透明质酸原料市场。这可归因于技术先进药物的日益采用,透明质酸在骨关节炎治疗程序中的广泛使用。此外,随着关节炎患病率的上升,骨科对透明质酸产品的需求也随之增加,因为这些产品被广泛用作治疗该病的补充剂,并进一步推动了该细分市场的增长。根据关节炎基金会,2019 年关节炎是美国残疾的主要原因,约有 9100 万人口患有关节炎。如此庞大的关节炎患者群体导致透明质酸原料的高度采用,并进一步推动了该细分市场的增长。

此外,随着美国透明质酸手术数量的增加,导致这些材料用于诊断关节炎的需求量很大,从而推动了透明质酸原料市场的发展。

img 3 Hyaluronic acid

北美有望成为最大市场,亚太地区有望实现最快增长

  • 北美处于该地区增长的最前沿,也是全球舞台上重要的收入贡献者。引进先进技术、完善的医疗保健基础设施以及提高患者对美容和抗衰老程序可用性的认识正在刺激该地区市场的增长。此外,对微创美容手术的需求不断增加,也促进了该地区的市场增长。根据美国整形外科医生协会的数据,2018 年在美国进行了约 1600 万次美容微创手术。透明质酸原料在改善皮肤效果的美容程序中的广泛使用正在促进该地区市场的增长。
  • 亚太地区可能是整个预测期内增长最快的市场。对微创医疗应用的认识不断提高、医疗需求未得到满足以及该地区可支配收入的增加是市场增长的一些因素。再加上医疗旅游的增加,预计将推动亚太地区的市场增长。
geography hyaluronic acid.png

竞争格局

透明质酸原料市场分散竞争,由几家主要参与者组成。就市场份额而言,目前很少有主要参与者占据市场主导地位。目前主导市场的一些公司 Genzyme Corporation、Allergan、Anika Therapeutics, Inc.、Zimmer Biomet、Sanofi、F. Hoffmann-La Roche Ltd、Salix Pharmaceuticals、Seikagaku Corporation、Smith & Nephew 和 Galderma SA

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Demand for Anti-Aging Solutions and Minimally Invasive Aesthetic Treatments

      2. 4.2.2 Demographic Shift in the Developed and Developing Countries

      3. 4.2.3 Growing Usage of Hyaluronic Acid in Cosmetic and Medical Field

    3. 4.3 Market Restraints

      1. 4.3.1 High Costs and Side Effects Associated with the Use of Hyaluronic Acid

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Application

      1. 5.1.1 Orthopedics

      2. 5.1.2 Ophthalmology

      3. 5.1.3 Drug Delivery

      4. 5.1.4 Dermatology

      5. 5.1.5 Others

    2. 5.2 By End User

      1. 5.2.1 Hospitals

      2. 5.2.2 Cosmetic Clinics

      3. 5.2.3 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Allergan Plc

      2. 6.1.2 Anika Therapeutics, Inc.

      3. 6.1.3 Genzyme Corporation

      4. 6.1.4 F. Hoffmann-La Roche Ltd.

      5. 6.1.5 Salix Pharmaceuticals

      6. 6.1.6 Zimmer Biomet

      7. 6.1.7 Seikagaku Corporation

      8. 6.1.8 Smith & Nephew Plc

      9. 6.1.9 Galderma S.A.

      10. 6.1.10 Lifecore Biomedical, LLC

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

[2/7 3:15 PM] Priyanka Vijay **Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The undefined market is studied from 2018 - 2026.

The undefined is growing at a CAGR of 6.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Genzyme Corporation, Allergan, Anika Therapeutics, Inc, Zimmer Biomet, Lifecore Biomedical, LLC are the major companies operating in undefined.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!